Cyclophosphamide Added to Glucocorticoids in Acute Exacerbation of Idiopathic Pulmonary Fibrosis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet Respiratory Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Cyclophosphamide added to glucocorticoids in acute exacerbation of idiopathic pulmonary fibrosis (EXAFIP): a randomised, double-blind, placebo-controlled, phase 3 trial
Lancet Respir Med 2021 Sep 07;[EPub Ahead of Print], JM Naccache, S Jouneau, M Didier, R Borie, M Cachanado, A Bourdin, M Reynaud-Gaubert, P Bonniaud, D Israël-Biet, G Prévot, S Hirschi, F Lebargy, S Marchand-Adam, N Bautin, J Traclet, E Gomez, S Leroy, F Gagnadoux, F Rivière, E Bergot, A Gondouin, E Blanchard, A Parrot, FX Blanc, A Chabrol, S Dominique, A Gibelin, A Tazi, L Berard, PY Brillet, MP Debray, A Rousseau, M Kerjouan, O Freynet, MC Dombret, AS Gamez, A Nieves, G Beltramo, J Pastré, A Le Borgne-Krams, T Dégot, C Launois, L Plantier, L Wémeau-Stervinou, J Cadranel, C Chenivesse, D Valeyre, B Crestani, V Cottin, T Simon, H NunesFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.